Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor: manufacturer/sponsor Abbott Bristol-Myers Squibb Roche Schering-Plough (confidential information, including appendix 3, removed) Wyeth This page was last updated: 24 June 2010